Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Viewpoint

Vol. 147 No. 0910 (2017)

Large vessel vasculitis: which imaging method?

  • Marco A Cimmino
  • Dario Camellino
DOI
https://doi.org/10.4414/smw.2017.14405
Cite this as:
Swiss Med Wkly. 2017;147:w14405
Published
01.03.2017

References

  1. Prieto-González S, Espígol-Frigolé G, García-Martínez A, Alba MA, Tavera-Bahillo I, Hernández-Rodríguez J, et al. The Expanding Role of Imaging in Systemic Vasculitis. Rheum Dis Clin North Am. 2016;42(4):733–51. doi:.https://doi.org/10.1016/j.rdc.2016.07.009
  2. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11. doi:.https://doi.org/10.1002/art.37715
  3. Adler S, Sprecher M, Wermelinger F, Klink T, Bonel HM, Villiger PM. Diagnostic value of contrast-enhanced magnetic resonance angiography in large-vessel vasculitis. Swiss Med Wkly. 2016;146:w14397.
  4. Rhéaume M, Rebello R, Pagnoux C, Carette S, Clements-Baker M, Cohen-Hallaleh V, et al. High-resolution Magnetic Resonance Imaging of scalp arteries for the diagnosis of giant cell arteritis: Results of a prospective cohort study. Arthritis Rheumatol. 2016 Aug 2. [Epub ahead of print] doi:. https://doi.org/10.1002/art.39824
  5. Puppo C, Massollo M, Paparo F, Camellino D, Piccardo A, Shoushtari Zadeh Naseri M, et al. Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography. BioMed Res Int. 2014;2014:574248. doi:.https://doi.org/10.1155/2014/574248
  6. Rehak Z, Vasina J, Ptacek J, Kazda T, Fojtik Z, Nemec P. PET/CT in giant cell arteritis: High (18)F-FDG uptake in the temporal, occipital and vertebral arteries. Rev Esp Med Nucl Imagen Mol. 2016;35(6):398–401. doi:. PubMed https://doi.org/10.1016/j.remn.2016.03.007
  7. Scheel AK, Meller J, Vosshenrich R, Kohlhoff E, Siefker U, Müller GA, et al. Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis. 2004;63(11):1507–10. doi:.https://doi.org/10.1136/ard.2003.015651
  8. Bley TA, Uhl M, Venhoff N, Thoden J, Langer M, Markl M. 3-T MRI reveals cranial and thoracic inflammatory changes in giant cell arteritis. Clin Rheumatol. 2007;26(3):448–50. doi:.https://doi.org/10.1007/s10067-005-0160-7
  9. Spira D, Xenitidis T, Henes J, Horger M. MRI parametric monitoring of biological therapies in primary large vessel vasculitides: a pilot study. Br J Radiol. 2016;89(1058):20150892. doi:.https://doi.org/10.1259/bjr.20150892
  10. Soussan M, Nicolas P, Schramm C, Katsahian S, Pop G, Fain O, et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine (Baltimore). 2015;94(14):e622. doi:.https://doi.org/10.1097/MD.0000000000000622
  11. Ginde S, Cava JR, Southern JF, Saudek DE. Delayed contrast-enhanced magnetic resonance imaging in the evaluation of Takayasu arteritis. J Am Coll Cardiol. 2012;59(12):e23. doi:.https://doi.org/10.1016/j.jacc.2011.06.084
  12. Hamrin B, Jonsson N, Hellsten S. “Polymyalgia arteritica”. Further clinical and histopathological studies with a report of six autopsy cases. Ann Rheum Dis. 1968;27(5):397–405. doi:.https://doi.org/10.1136/ard.27.5.397
  13. Grayson PC. Lumpers and splitters: ongoing issues in the classification of large vessel vasculitis. J Rheumatol. 2015;42(2):149–51. doi:.https://doi.org/10.3899/jrheum.141376
  14. Camellino D, Cimmino MA. Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis. Rheumatology (Oxford). 2012;51(1):77–86. doi:.https://doi.org/10.1093/rheumatology/keq450